ReSCon '12, Research Student Conference: Book of Abstracts

The fifth SED Research Student Conference (ReSCon2012) was hosted over three days, 18-20 June 2012, in the Hamilton Centre at Brunel University. The conference consisted of 130 oral and 70 poster presentations, based on the high quality and diverse research being conducted within the School of Engineering and Design by postgraduate research students. The conference is held annually, and ReSCon plays a key role in contributing to research and innovations within the School

Geotechnical Engineering for the Preservation of Monuments and Historic Sites III

The conservation of monuments and historic sites is one of the most challenging problems facing modern civilization. It involves, in inextricable patterns, factors belonging to different fields (cultural, humanistic, social, technical, economical, administrative) and the requirements of safety and use appear to be (or often are) in conflict with the respect of the integrity of the monuments. The complexity of the topic is such that a shared framework of reference is still lacking among art historians, architects, structural and geotechnical engineers. The complexity of the subject is such that a shared frame of reference is still lacking among art historians, architects, architectural and geotechnical engineers. And while there are exemplary cases of an integral approach to each building element with its static and architectural function, as a material witness to the culture and construction techniques of the original historical period, there are still examples of uncritical reliance on modern technology leading to the substitution from earlier structures to new ones, preserving only the iconic look of the original monument. Geotechnical Engineering for the Preservation of Monuments and Historic Sites III collects the contributions to the eponymous 3rd International ISSMGE TC301 Symposium (Naples, Italy, 22-24 June 2022). The papers cover a wide range of topics, which include: 　 - Principles of conservation, maintenance strategies, case histories - The knowledge: investigations and monitoring - Seismic risk, site effects, soil structure interaction - Effects of urban development and tunnelling on built heritage - Preservation of diffuse heritage: soil instability, subsidence, environmental damages The present volume aims at geotechnical engineers and academics involved in the preservation of monuments and historic sites worldwide

Друга міжнародна конференція зі сталого майбутнього: екологічні, технологічні, соціальні та економічні питання (ICSF 2021). Кривий Ріг, Україна, 19-21 травня 2021 року

Second International Conference on Sustainable Futures: Environmental, Technological, Social and Economic Matters (ICSF 2021). Kryvyi Rih, Ukraine, May 19-21, 2021.Друга міжнародна конференція зі сталого майбутнього: екологічні, технологічні, соціальні та економічні питання (ICSF 2021). Кривий Ріг, Україна, 19-21 травня 2021 року

Drug development progress in duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of functional dystrophin protein, which results in chronic damage of muscle fibers during contraction, thus leading to deterioration of muscle quality and loss of muscle mass over time. Although there is currently no cure for DMD, improvements in treatment care and management could delay disease progression and improve quality of life, thereby prolonging life expectancy for these patients. Furthermore, active research efforts are ongoing to develop therapeutic strategies that target dystrophin deficiency, such as gene replacement therapies, exon skipping, and readthrough therapy, as well as strategies that target secondary pathology of DMD, such as novel anti-inflammatory compounds, myostatin inhibitors, and cardioprotective compounds. Furthermore, longitudinal modeling approaches have been used to characterize the progression of MRI and functional endpoints for predictive purposes to inform Go/No Go decisions in drug development. This review showcases approved drugs or drug candidates along their development paths and also provides information on primary endpoints and enrollment size of Ph2/3 and Ph3 trials in the DMD space